BC
CBIO

Broadfin Capital’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Broadfin Capital’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,218
Closed -$2.48M – 47
2017
Q2 		$2.48M Buy
+2,218
New +$2.48M 0.3% 39